ABUSVSCDT• 28 Days (Normalized)
ABUS vs CDT (Arbutus Biopharma Corporation vs CDT Equity Inc.)
Showing Closing Date Range from Sep 10 to Oct 8, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ABUS Performance $4.18
-18.36%
Arbutus Biopharma Corporation
Normalized Baseline0.00%
CDT Performance $0.8
-90.72%
CDT Equity Inc.
Normalized Baseline0.00%
Alpha Spread Margin ABUS LEADS
+72.36 pts
ABUS outperforming by 72.36 percentage points
ABUSCDT
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ABUS CDT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(21 dates)
| Date | ABUS Price | ABUS Gain (%) | CDT Price | CDT Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 08, 2026 | $4.18 | -18.36% | $0.80 | -90.72% | +72.36% |
| Oct 07, 2026 | $4.29 | -16.21% | $0.84 | -90.31% | +74.10% |
| Oct 06, 2026 | $4.48 | -12.50% | $0.93 | -89.22% | +76.72% |
| Oct 05, 2026 | $4.67 | -8.79% | $0.92 | -89.36% | +80.57% |
| Oct 02, 2026 | $4.45 | -13.09% | $0.99 | -88.52% | +75.43% |
| Oct 01, 2026 | $4.56 | -10.94% | $1.25 | -85.51% | +74.57% |
| Sep 30, 2026 | $4.78 | -6.64% | $1.36 | -84.23% | +77.59% |
| Sep 29, 2026 | $4.69 | -8.40% | $1.45 | -83.19% | +74.79% |
| Sep 28, 2026 | $4.86 | -5.08% | $1.90 | -77.97% | +72.89% |
| Sep 25, 2026 | $4.85 | -5.27% | $2.00 | -76.81% | +71.54% |
| Sep 24, 2026 | $4.88 | -4.69% | $3.03 | -64.93% | +60.24% |
| Sep 23, 2026 | $4.85 | -5.27% | $3.38 | -60.87% | +55.60% |
| Sep 22, 2026 | $5.01 | -2.15% | $3.55 | -58.84% | +56.69% |
| Sep 21, 2026 | $5.00 | -2.34% | $3.85 | -55.36% | +53.02% |
| Sep 18, 2026 | $5.01 | -2.15% | $4.35 | -49.57% | +47.42% |
Page 1 of 2